Log In Sign up
The largest database of trusted experimental protocols

Anti human vegf

Manufactured by R&D Systems
Visit Supplier
Sourced in United States

Anti-human VEGF is a laboratory reagent used for research purposes. It is a protein that binds to and neutralizes the activity of human vascular endothelial growth factor (VEGF), a key regulator of angiogenesis. This product is intended for use in in vitro experiments and assays to study the role of VEGF in various biological processes.

Automatically generated - may contain errors

Lab products found in correlation

Anti mouse il 10, by R&D Systems (1 mentions) Anti mouse vegf, by R&D Systems (1 mentions) Normal goat igg control, by R&D Systems (1 mentions) Recombinant human vegf165, by R&D Systems (1 mentions) Anti human vegfr1, by R&D Systems (1 mentions) M csf, by R&D Systems (1 mentions) Rankl, by R&D Systems (1 mentions)

Spelling variants of this product

Human VEGF (21 citations) Anti-VEGF (10 citations) Goat-anti-human VEGF-R3 (3 citations) Biotinylated goat anti-human VEGF (3 citations) Goat anti-human VEGF (2 citations) Human PE-conjugated anti-VEGF-A antibody (2 citations)

2 protocols using anti human vegf

1

Blocking Antibodies and Mcl-1 Inhibitor Treatment

Check if the same lab product or an alternative is used in the 5 most similar protocols
The following blocking antibodies were used: 10–20 μg/mL anti-mouse GM-CSF blocking antibody (eBioscience, San Diego, CA, USA), 20 μg/mL anti-mouse VEGF, 20 μg/mL anti-mouse IL-10, 10 μg/mL anti-human GM-CSF, 10 μg/mL anti-human VEGF and 20 μg/mL anti-human IL-10 blocking antibodies (R&D systems, Minneapolis, MN, USA). Isotype controls used were 10 μg/mL rat IgG2aK isotype control (eBioscience) and normal goat IgG control (R&D). Mcl-1 inhibitor MIM1 (R&D) was dissolved in DMSO.
De Veirman K., Van Ginderachter J.A., Lub S., De Beule N., Thielemans K., Bautmans I., Oyajobi B.O., De Bruyne E., Menu E., Lemaire M., Van Riet I., Vanderkerken K, & Van Valckenborgh E. (2015). Multiple myeloma induces Mcl-1 expression and survival of myeloid-derived suppressor cells. Oncotarget, 6(12), 10532-10547.
+ Open protocol
+ Expand
2

Inhibitors of Angiogenesis Signaling Pathways

Check if the same lab product or an alternative is used in the 5 most similar protocols
Recombinant human VEGF165, RANKL, and macrophage colony-stimulating factor (M-CSF) were purchased from R&D Systems (Minneapolis, MN). Inhibitors of signal molecules such as Src inhibitor (PP1), protein kinase C (PKC) inhibitor (PKC inhibitor peptide) and P38 mitogen-activated protein kinase (MAPK) inhibitor (SB203580) were obtained from Calbiochem (Schwalbach, Germany). Anti-human VEGF, Anti-human VEGFR1, Anti-human VEGFR2 and anti-CD55 antibodies were purchased from R&D Systems.
Kim H.R., Kim K.W., Kim B.M., Cho M.L, & Lee S.H. (2015). The Effect of Vascular Endothelial Growth Factor on Osteoclastogenesis in Rheumatoid Arthritis. PLoS ONE, 10(4), e0124909.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!